What's Happening?
The Mammo 2026 OncoDaily Breast Cancer Congress is a global virtual event focused on advancing breast cancer care through early diagnosis, risk stratification, and innovative treatment strategies. The congress addresses the global health priority of breast cancer,
which is the most commonly diagnosed cancer worldwide. With over 2.3 million new cases annually, the congress emphasizes the importance of early detection and advanced care in improving survival rates. The event features a comprehensive program exploring the full clinical spectrum of breast cancer, including contemporary approaches to screening, risk-adapted decision-making, and innovative strategies for metastatic and triple-negative breast cancer.
Why It's Important?
Breast cancer remains a significant health challenge, and the Mammo 2026 Congress plays a crucial role in disseminating the latest research and treatment strategies to healthcare professionals worldwide. The congress highlights the progress made in early detection and treatment, which has led to a 44% decline in breast cancer mortality since 1989. By focusing on evidence-based management and personalized care, the event aims to improve patient outcomes and reduce the global burden of breast cancer. The congress also underscores the importance of multidisciplinary coordination and individualized patient care in achieving optimal treatment results.
